The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals

OBJECTIVES: There remains ongoing debate regarding the relative efficacy of public (NIH) and private sector funding in bringing biopharmaceutical innovations to market. This paper investigates the significance of each party’s level of funding for obtaining Food and Drug Administration (FDA) authoriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulthess, Duane, Bowen, Harry P., Popovian, Robert, Gassull, Daniel, Zhang, Augustine, Hammang, Joe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440766/
https://www.ncbi.nlm.nih.gov/pubmed/36057746
http://dx.doi.org/10.1007/s43441-022-00451-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440766/
https://www.ncbi.nlm.nih.gov/pubmed/36057746
http://dx.doi.org/10.1007/s43441-022-00451-8

Ejemplares similares